GARIGLIO, Marisa
 Distribuzione geografica
Continente #
NA - Nord America 1.205
EU - Europa 679
AS - Asia 309
AF - Africa 21
SA - Sud America 6
OC - Oceania 2
Totale 2.222
Nazione #
US - Stati Uniti d'America 1.199
CN - Cina 186
IT - Italia 130
IE - Irlanda 113
SE - Svezia 85
FR - Francia 78
FI - Finlandia 45
AT - Austria 42
GB - Regno Unito 40
KR - Corea 39
DE - Germania 38
PL - Polonia 38
SG - Singapore 34
UA - Ucraina 32
VN - Vietnam 20
SN - Senegal 19
IN - India 16
DK - Danimarca 12
NL - Olanda 9
BE - Belgio 6
CA - Canada 5
JP - Giappone 5
CH - Svizzera 4
EC - Ecuador 4
HK - Hong Kong 3
PH - Filippine 3
RU - Federazione Russa 3
AU - Australia 2
BR - Brasile 2
ZA - Sudafrica 2
ES - Italia 1
HR - Croazia 1
MX - Messico 1
MY - Malesia 1
PT - Portogallo 1
RS - Serbia 1
TH - Thailandia 1
TW - Taiwan 1
Totale 2.222
Città #
Chandler 261
Dublin 112
Beijing 110
Ann Arbor 71
Villeurbanne 55
Torino 52
Jacksonville 50
Woodbridge 42
Princeton 41
Vienna 38
Warsaw 38
Fairfield 35
New York 34
Dearborn 32
Nyköping 29
Pisa 28
Houston 26
Ashburn 25
Medford 25
Wilmington 22
Boston 21
Singapore 19
Guangzhou 15
Fremont 13
Orange 13
Seattle 11
Dong Ket 10
Blackwood 9
Boardman 8
Cambridge 8
Redwood City 7
Shanghai 7
Zhengzhou 7
Falls Church 5
Piemonte 5
San Mateo 5
Brussels 4
Nanjing 4
Philadelphia 4
Bethesda 3
Hefei 3
London 3
Los Angeles 3
San Diego 3
Tokyo 3
Utrecht 3
Verona 3
Washington 3
Wuhan 3
Cassano Magnago 2
Central District 2
Des Moines 2
Düsseldorf 2
Fuzhou 2
Hamburg 2
Heidelberg 2
Jinan 2
Klaus 2
Kunming 2
Latacunga 2
Liverpool 2
Melzo 2
Milan 2
Nanchang 2
Nepi 2
Norwalk 2
Novara 2
Oxford 2
Paris 2
Quito 2
Recife 2
Tappahannock 2
Toronto 2
Vernante 2
Xian 2
Zurich 2
Amsterdam 1
Baotou 1
Belgrade 1
Bellville 1
Bhopal 1
Canberra 1
Cardiff 1
Chicago 1
Chigwell 1
Chongqing 1
Ciriè 1
Coimbatore 1
Como 1
Cork 1
Cormeilles-en-Parisis 1
Denton 1
Durham 1
Eltham 1
Fallbrook 1
Florence 1
Framingham 1
Frankfurt am Main 1
Frederick 1
Gainesville 1
Totale 1.409
Nome #
HPV18 Persistence Impairs Basal and DNA Ligand-Mediated IFN-β and IFN-λ1 Production through Transcriptional Repression of Multiple Downstream Effectors of Pattern Recognition Receptor Signaling. 151
The absent in melanoma 2-like receptor IFN-inducible protein 16 as an inflammasome regulator in systemic lupus erythematosus: The dark side of sensing microbes 136
Evasion strategy of Human Cytomegalovirus from the antiviral activities of APOBEC3G 129
HPV8 Field Cancerization in a Transgenic Mouse Model Is due to Lrig1+ Keratinocyte Stem Cell Expansion 122
La proteina interferon-inducibile ifi16: fattore di restrizione per la replicazione degli herpesvirus umani 116
Strategy of Human Cytomegalovirus To Escape Interferon Beta-Induced APOBEC3G Editing Activity 106
THE ROLE OF ANTI-IFI16 ANTIBODIES IN THE MANAGEMENT OF INFLAMMATORY BOWEL DISEASES (IBD) 105
HUMAN CYTOMEGALOVIRUS INFECTION TRIGGERS THE INTERFERON RESPONSE VIA THE DNA SENSOR IFI16 IN HUMAN KERATINOCYTES 101
Early stage IFI16 cytoplasmic translocation and late stage entrapment into egressing virions during HCMV infection 100
β-HPV infection correlates with early stages of carcinogenesis in skin tumors and patient-derived xenografts from a kidney transplant recipient cohort 96
Evasion Strategy of Human Cytomegalovirus to Escape Interferon-β-Induced APOBEC3G Editing Activity 86
Cell and type specificity of interferon action. Unusual characteristics of the transcriptional control of gene expression by interferon-gamma in T cells. 73
Characterization of cytoplasmic and nuclear polypeptides induced by interferon-gamma in a murine pre-B cell leukemia. 73
The interferon-inducible 204 gene, a member of the Ifi 200 family, is not involved in the antiviral state induction by IFN-alpha, but is required by the mouse cytomegalovirus for its replication. 71
Frequency of methicillin resistance varies with conditions, in a population of staphylococci from a hospital environment 70
CLINICAL SIGNIFICANCE OF ANTI-IFI16 AUTOANTIBODIES IN SYSTEMIC AUTOIMMUNE DISEASES 69
Murine cytomegalovirus replication in salivary glands is controlled by both perforin and granzymes during acute infection. 65
Host genotype controls the ability of the ISGF3 complex to activate transcription of IFN-inducible genes. 64
Detection of IFI16 in body fluids 63
Extracellular IFI16 as therapeutic agent 60
Interferon-gamma is not an antiviral, but a growth-promoting factor for T lymphocytes. 59
Inhibition of interferon-gamma antiviral and antiproliferative activities by ras oncogene expression. 58
The HMG protein T160 colocalizes with DNA replication foci and is down-regulated during cell differentiation. 58
Demonstration of multiple HPV types in laryngeal premalignant lesions using polymerase chian reaction and immunohistochemistry. 56
Impaired transcription of the poly rI:rC- and interferon-activatable 202 gene in mice and cell lines from the C57BL/6 strain. 53
Detection of anti-IFI16 antibodies by ELISA: clinical and serological associations in systemic sclerosis. 48
Suppression of high mobility group protein T160 expression impairs mouse cytomegalovirus replication. 41
Prevention of diabetes in BB/Wor rats treated with monoclonal antibodies to interferon-gamma. 40
The high-mobility group protein T160 binds to both linear and cruciform DNA and mediates DNA bending as determined by ring closure. 33
Totale 2.302
Categoria #
all - tutte 6.539
article - articoli 0
book - libri 0
conference - conferenze 1.792
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.331


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020226 6 8 13 18 13 37 25 20 19 37 11 19
2020/2021253 21 15 15 18 20 14 22 24 37 25 15 27
2021/2022292 4 12 5 22 15 5 15 22 4 20 104 64
2022/2023658 44 20 15 63 87 149 33 60 124 18 28 17
2023/2024202 33 32 13 7 8 41 12 6 2 11 11 26
2024/20252 2 0 0 0 0 0 0 0 0 0 0 0
Totale 2.302